Thai Health Experts Get WHO Help To Overcome Vaccine Delay
This article was originally published in PharmAsia News
Executive SummaryThailand's Government Pharmaceutical Organization says the World Health Organization is helping it deal with problems in developing an H1N1 flu vaccine. The Thai effort has encountered a hurdle in obtaining more than a low yield from the viruses it has been growing in eggs. The WHO is conferring with the GPO and the Public Health Ministry on how to improve the yield. The first trial of a vaccine in Thailand, originally scheduled to begin Sept. 4, now faces a two-month delay because of the problems. (Click here for more
You may also be interested in...
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.